Qualigen Therapeutics, Inc. - LOGO.jpg
Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
March 19, 2018 06:35 ET | Ritter Pharmaceuticals, Inc.
LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate...
Chapman Global Medical Center Achieves National Accreditation and Recognition for Metabolic and Bariatric Surgery
March 08, 2018 05:00 ET | KPC Healthcare Inc.
Orange County, CA, March 08, 2018 (GLOBE NEWSWIRE) -- Patients seeking surgical treatment for severe obesity and its related conditions have a high-quality choice for receiving treatment. Chapman...
Qualigen Therapeutics, Inc. - LOGO.jpg
Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase 3 Clinical Trial
January 29, 2018 09:00 ET | Ritter Pharmaceuticals, Inc.
LOS ANGELES, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutics that modulate the human gut...
MicroBiome Therapeutics Completes Series B Financing and Prepares to Launch First Microbiome Modulator Product
November 01, 2017 07:00 ET | MicroBiome Therapeutics, LLC
NEW ORLEANS, La., Nov. 01, 2017 (GLOBE NEWSWIRE) -- MicroBiome Therapeutics, LLC (MBT), a leading company applying the science of the gastrointestinal (GI) microbiome to promote health and wellness,...
Qualigen Therapeutics, Inc. - LOGO.jpg
Ritter Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
October 31, 2017 06:45 ET | Ritter Pharmaceuticals, Inc.
LOS ANGELES, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (“Ritter Pharmaceuticals” or the “Company”), a pharmaceutical company developing novel therapeutic products...
Qualigen Therapeutics, Inc. - LOGO.jpg
Ritter Pharmaceuticals, Inc. Prices $23,000,000 Public Offering
September 29, 2017 08:00 ET | Ritter Pharmaceuticals
Los Angeles, California, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutic products...
Clinical "CSI" for Your Body
February 11, 2008 10:30 ET | LaValle Metabolic Institute
CINCINNATI, OH--(Marketwire - February 11, 2008) - Don't beat yourself up if your resolution to lose a few pounds fails. It may not be your fault. Metabolic expert Jim LaValle says if you've always...